Home | Site Index | Contact Us  
 
 
Valeant's core products can be categorized into one of our three therapeutic areas: Dermatology, Infectious Disease and Neurology. Valeant focuses promotional efforts on ten global products, but also has a number of other successful regional products throughout the world. For information on our products, please see the links below.

For additional information, please contact Customer Service at 1.800.556.1937.
  Global Products
VIRAMIDINE, PRADEFOVIR and RETIGABINE are products in clinical development. None of them have been found to be safe or effective for the treatment of any disease or illness. They may not be sold or promoted in the United States unless and until they are approved by the FDA. Similar restrictions apply in other countries.
  Other Selected Regional Products
     
 
 
North America
 
 
 
Bontril
 
Cesamet
 
Librax®
 
Ancobon/Ancotil
 
Android®
 
PB 210's
 
Glyquin®
 
C.E.S®
 
Gly Derm®
 
Tryptan
 
Melformin (glycon)
 
Librium®
 
Carbolith
 
Testred
 
Limbitrol®
 
Mogadon
 
Prostigmin
 
Dalmane®/Dalmadorm
 
Flourouracil®
 
Permax
 
Diastat®
 
Mysoline®
 
Migranal®
 
D.H.E. 45®
   
 
 
 
Europe
 
 
Vision Care
 
Dalmane/Dalmadorm®
 
Bisocard
 
Omeprazol
 
Calcitonin
 
Aclotin
 
Librax®
 
Gerbin
 
Chlorchinaldin
 
Protamin
 
Limbitrol®
 
Ancobon/Ancotil
 
Mogadon
 
Flourouracil®
 
Maxaquin
 
Cronocef
 
Nifedicor
 
Librium
 
Prostigmin
 
Eupress
 
Mizar
 
Solco Seryl Injections
 
Solcoseryl Dental Paste
    Glibonuride
   
 
 
 
Latin & South America
 
 
Bedoyecta®
 
M.V.I.®
 
Espaven®
 
Espacil
 
Firac
 
Alivin
 
Anapenil®
 
Yectamicina®
 
Limbitrol
 
Prostigmin
 
Dalmane/Dalmadorm®
 
Flourouracil®
 
Librax®
 
Protamin
 
Mogadon
 
Alloferin
 
 
 
 
 
Asia, Australia, Africa
 
 
Nyal®
 
Reptilase
 
Solco Seryl Injections
 
Dislatyl
 
Coracten®
 
Librax®
 
Prostigmin
 
Mogadon
 
Flourouracil®
Fefol®  
Dalmane/Dalmadorm  
Ancobon/Ancotil  
       
   
   
       
   
 


   Listing of all Valeant products in a PDF format


VIRAMIDINE, PRADEFOVIR and RETIGABINE are products in clinical development. None of them have been found to be safe or effective for the treatment of any disease or illness. They may not be sold or promoted in the United States unless and until they are approved by the FDA. Similar restrictions apply in other countries.

© Valeant Pharmaceuticals International 2005
Legal and Privacy Statement